Browsing Category

Supplier News

131 posts

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

From DCAT Week 2023: Supplier News: Packaging
By

By
A roundup of news from CDMOs/CMOs and suppliers in pharmaceutical packaging with news from PCI Pharma Services, Bormioli, and Tedor Pharma Services. Highlights below.   * PCI Pharma Services Investing $50…

From DCAT Week 2023: Supplier News: End-to-End (Drug Substance and Drug Product) Mfg
By

By
A roundup of news from CDMOs/CMOs and suppliers in both drug-substance and drug-product development and manufacturing with news from CordenPharma and BioDuro Sundia. Highlights below.   * CordenPharma Expanding Peptide &…

From DCAT Week 2023: Supplier News: Biologics Manufacturing
By

By
A roundup of news from CDMOs/CMOs and suppliers in biomanufacturing, including advanced therapies, with news from BioVectra, Scorpius BioManufacturing, Avid Bioservices, IDT Biologika, Landmark Bio, and Mabion. Highlights below.   *…

From DCAT Week 2023: Supplier News: Chemicals/Chemical API Manufacturing
By

By
The latest news for CDMOs/CMOs and suppliers involved in the development and manufacturing of chemicals and chemical active pharmaceutical ingredients (APIs) with news from PharmaBlock, Seqens, Polpharma API, Cambrex, Actylis,…

From DCAT Week 2023: Supplier News: Formulation Development/Drug Product Manufacturing
By

By
The latest news from CMDOs/CMOs and suppliers involved in formulation development and drug-product manufacturing with news from Evonik, Carbogen Amcis, Vetter, Nanoform, Mikart, Ascendia Pharmaceuticals, Bushu Pharma, and Lifecore Biomedical.…

From DCAT Week: Kindeva Drug Delivery and Meridian Medical Technologies Merge To Create New Drug–Device CDMO 
By

By
A new drug–device CDMO, which merged Kindeva Drug Delivery (formerly 3M Drug Delivery Systems), a CDMO of drug-delivery services, and Meridian Medical Technologies, a Saint Louis, Michigan-based CDMO of autoinjectors,…

From DCAT Week: Porton Pharma Solutions Expanding Drug-Substance and Drug-Product Capacity 
By

By
Porton Pharma Solutions, a CDMO of active pharmaceutical ingredients (APIs) and drug products, is heavily investing in its drug-substance and drug-product research and manufacturing capacities. This includes expansions to current…

From DCAT Week: Thermo Fisher Scientific Outlines Multi-Segment Expansions 
By

By
Thermo Fisher Scientific is proceeding with a series of investments to expand capacity in cell and gene therapies, drug products, and biomanufacturing. Leon Wyszkowski, President of Commercial Operations, Pharma Services,…

From DCAT Week: WuXi Biologics’ Growing Global Footprint 
By

By
WuXi Biologics, a contract research, development, and manufacturing organization (CRDMO), continues to enhance its global manufacturing network by increasing its global capacity to meet growing clients needs around the world.…

From DCAT Week: Siegfried Expands Drug-Product and Small-Molecule API Capacity 
By

By
Siegfried, a CDMO of active pharmaceutical ingredients (APIs) and drug products, recently invested $190 million to expand its footprint in small-molecule and biopharmaceutical fill–finish capacity and capabilities. Marianne Späne, Executive…